The Effects of Radium-223 Dichloride Therapy on Radionuclide Bone Scan Lesions.

Condition:   Bony Metastases From Castrate Refractory Prostate Cancer Intervention:   Drug: Radium-223 dichloride Sponsor:   The University of Texas Health Science Center, Houston Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials